Gene · 4900
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy. | J Clin Med | 2023 | 37568462 | PubTator, text mining | PubMed |
| Fine-grained cell-type specific association studies with human bulk brain data using a large single-nucleus RNA sequencing based reference panel. | Sci Rep | 2023 | 37563216 | PubTator, text mining | PubMed |
| Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias. | Mol Cell Proteomics | 2023 | 37557955 | PubTator, text mining | PubMed |
| High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease. | Ann Clin Transl Neurol | 2023 | 37553789 | PubTator, text mining | PubMed |
| Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic. | Front Aging Neurosci | 2023 | 37547746 | PubTator, text mining | PubMed |
| How should we be using biomarkers in trials of disease modification in Parkinson's disease? | Brain | 2023 | 37536279 | PubTator, text mining | PubMed |
| Epilepsy and nodding syndrome in association with an Onchocerca volvulus infection drive distinct immune profile patterns. | PLoS Negl Trop Dis | 2023 | 37535695 | PubTator, text mining | PubMed |
| Effect of exercise engagement and cardiovascular risk on neuronal injury. | Alzheimers Dement | 2023 | 37534906 | PubTator, text mining | PubMed |
| Virus-Based Biological Systems as Next-Generation Carriers for the Therapy of Central Nervous System Diseases. | Pharmaceutics | 2023 | 37514117 | PubTator, text mining | PubMed |
| Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges. | Int J Mol Sci | 2023 | 37511539 | PubTator, text mining | PubMed |
| A Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia (MAINSTREAM): A Study Protocol. | Brain Sci | 2023 | 37508992 | PubTator, text mining | PubMed |
| Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study. | Alzheimers Dement | 2023 | 37491668 | PubTator, text mining | PubMed |
| Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease. | Mol Neurodegener | 2023 | 37468915 | PubTator, text mining | PubMed |
| A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease. | Genome Med | 2023 | 37468900 | PubTator, text mining | PubMed |
| Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum. | Acta Neuropathol | 2023 | 37466726 | PubTator, text mining | PubMed |
| Decreased DHA-containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ42 , phosphorylated α-synuclein, and synaptopathology. | Brain Pathol | 2023 | 37463072 | PubTator, text mining | PubMed |
| Editorial: Neuroimaging insights into the link between sleep disturbances and neuropsychiatric disorders. | Front Psychiatry | 2023 | 37457768 | PubTator, text mining | PubMed |
S14G-Humanin ameliorates ovalbumin-induced airway inflammation in asthma mediated by inhibition of toll-like receptor 4 (TLR4) expression and the nuclear factor κ-B (NF-κB)/early growth response protein-1 (Egr-1) pathway. | Aging (Albany NY) | 2023 | 37451839 | PubTator, text mining | PubMed |
| Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review. | Int J Mol Sci | 2023 | 37446307 | PubTator, text mining | PubMed |
| The QPLEX™ Plus Assay Kit for the Early Clinical Diagnosis of Alzheimer's Disease. | Int J Mol Sci | 2023 | 37446296 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4900/papers?page=14